from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1990c/-

LFCtreatmentdescriptionclass of inhibitor

1.426

Amikacinug/mL Amikacintranslation

1.224

Cap5-10ug/mL Capreomycintranslation

3.093

Rox10-50 ug/mL Roxithromycintranslation

-0.118

SM2-5 ug/mL Streptomycintranslation

1.933

Tet5-10 ug/mL Tetracyclinetranslation

-0.802

Rif0.2-5ug/mL Rifampicintranscription

-0.870

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.554

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.508

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.173

CPZ10-50 ug/mL Chlorpromazinerespiration

0.569

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.324

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.223

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.653

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.163

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.276

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.168

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.007

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.514

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.014

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.689

KCN5-20 ug/mL Potassium cyaniderespiration

0.130

NaN30.2-2 mM Sodium aziderespiration

0.182

Nigericin50 uM Nigericinrespiration

0.410

TRC10-150 ug/mL Triclosanrespiration

1.992

TRZ10-25 ug/mL Thioridazinerespiration

2.982

Valinomycin0.5-10 uM Valinomycinrespiration

-1.515

ZnSO42 mM ZnSO4respiration

0.146

menadione6-10 ug/mL Menadionerespiration

-0.467

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.609

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.546

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.251

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.448

NRP_1Non-replicating persistence stage 1dosRassociated

-0.427

Amp0.2mg/mL AmpicillincellWall

-0.198

Cephalexin20-100 ug/mL CephalexincellWall

-0.612

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.667

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.285

EMB10-20 ug/mL EthambutolcellWall

-0.310

Eta12-40 ug/mL EthionamidecellWall

-0.361

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.404

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.437

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.518

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.361

BZA0.12 mg/mL BenzamidearomaticAmides

-0.264

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.206

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.258

H2O24 mM hydrogen peroxideDNAdamaging

-0.421

Levo10 ug/mL LevofloxacinDNAdamaging

-0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.002

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.649

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.707

UVUV-irradiationDNAdamaging

-0.275

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.410

Antimycin12.5-50 ug/mL Antimycin A?

-0.406

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.460

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.510

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.248

PA8240.2-2 ug/mL PA-824?

-0.453

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.742

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.043

Verapamil50 uM Verapamil?

-0.203

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.471

methoxatin10-20 ug/mL Methoxatin?